查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462690

電阻分析儀的全球市場預測（截至 2030 年）：按產品類型、模式、使用類型、應用、最終用戶和地區進行分析

Bioimpedance Analyzers Market Forecasts to 2030 - Global Analysis By Product Type (Single-frequency, Dual-frequency and Multi-frequency), By Modality (Wired and Wireless), Usage Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

2023年全球生物阻抗電阻市場規模為5.305億美元，預計到2030年將達到10.877億美元，預測期內年複合成長率為10.8%。生物阻抗電阻是一種測量活體組織電電阻的裝置。

透過使微電流通過身體並測量產生的電壓，它可以估計身體組成參數，例如脂肪量、去脂體重和總水分。它通常用於醫療保健、健身和研究環境中，以評估水合狀態並監測身體組成隨時間的變化。

根據國際糖尿病聯盟（IDF）2021年發布的資料，2021年全球整體20歲至79歲的糖尿病患者人數將達5.37億人。

慢性疾病和肥胖的增加

生物阻抗電阻對於評估脂肪量、肌肉量和水合程度等身體組成至關重要，這些都是健康狀況和疾病風險的重要指標。隨著糖尿病、心血管疾病和與肥胖相關的代謝紊亂等慢性疾病在全球範圍內的增加，對生物阻抗電阻等有助於早期檢測、監測和管理的工具的需求不斷成長，從而推動市場佔有率的成長。

生物阻抗電阻高成本

先進生物阻抗電阻的高成本是電阻分析儀市場的主要限制。這些具有先進功能和性能的先進設備通常價格昂貴，限制了某些人群和醫療機構的使用。此外，購買和維護這些分析儀所需的初始投資可能會降低潛在的購買意願，尤其是在資源有限的環境中。

家庭醫療保健中擴大採用生物阻抗電阻

這些設備為使用者提供了在舒適的家中監測身體組成和健康參數的便利，使個人能夠採取積極主動的措施來更好地管理自己的健康。隨著遠端醫療和遠端患者監護的興起，生物阻抗電阻可以促進及時干涉和個人化護理計劃。此外，可攜式和方便用戶使用型設計的進步將提高可訪問性，並鼓勵尋求便捷健康監測解決方案的消費者廣泛採用。

與替代身體組成分析方法的競爭

雙能量X光檢測法（DEXA）和空氣置換體積描記法（ADP）比電阻分析更準確和準確。儘管生物阻抗電阻方便且非侵入性，但有時在臨床和研究環境中它們被認為不太準確。這種競爭對市場成長提出了挑戰，有可能將需求轉向更成熟、更可靠的技術，特別是在準確的身體組成測量至關重要的應用中，例如醫療診斷和運動表現分析。

COVID-19 的影響：

COVID-19 的爆發對生物阻抗電阻市場既有正面的影響，也有負面的影響。儘管疫情提高了人們對健康監測和健身的認知，但製造、供應鏈和醫療保健服務的中斷阻礙了市場的成長。然而，隨著醫療保健系統的復甦以及大流行後預防性護理和遠端患者監護的重新關注，市場預計將復甦。

預計身體測量部分在預測期內將是最大的

在預測期內，生物阻抗電阻市場預計將由身體部位測量領域主導。這主要是由於人們越來越重視個人健身和醫療保健，以及對精確身體組成分析的需求不斷增加。此外，技術進步促進了生物阻抗電阻的發展，可以準確測量不同部位的身體成分，從而可以在體重管理、最佳化運動表現和疾病預防等領域進行有針對性的干涉。

預計多頻細分市場在預測期內年複合成長率最高

預計在預測期內，生物阻抗電阻市場的多頻部分將呈現顯著成長。這是由於擴大採用多頻生物阻抗電阻，提高了身體組成測量的準確性和可靠性。這些分析儀透過評估體內的各種組織和液體室來提供更全面的資料，滿足醫療保健、健身和研究應用中對先進和精確的身體組成分析不斷成長的需求。

佔比最大的地區：

北美預計將保持其在生物阻抗電阻市場的主導地位。這主要得益於發達的醫療基礎設施、先進醫療技術的高採用率以及預防性醫療措施意識增強等因素。此外，持續的研發活動和政府積極促進醫療創新預計將進一步推動該地區的市場成長，並鞏固北美在生物阻抗電阻市場的主導地位。

年複合成長率最高的地區：

亞太地區是生物阻抗電阻市場成長最快的地區。慢性病的增加、醫療保健支出的增加以及預防性醫療保健措施意識的增強等因素正在推動該地區的市場擴張。此外，醫療基礎設施的改善、技術的進步和龐大的人口也促進了生物阻抗電阻需求的快速成長。由於這些因素，亞太地區擁有顯著的成長機會，並在全球生物阻抗電阻市場中佔據重要地位。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球生物阻抗電阻市場：依產品類型

  • 單頻
  • 雙頻
  • 多頻

第6章全球生物阻抗電阻市場：按模式

  • 有線
  • 無線的

第7章全球生物阻抗電阻市場：依使用類型

  • 消費級
  • 專業級

第8章全球生物阻抗電阻市場：依應用

  • 生物回饋療法和訓練
  • 身體水分監測
  • 健身和健美
  • 醫學診斷
  • 營養評估
  • 依身體部位測量身體尺寸
  • 全身身體組成測量

第9章全球生物阻抗電阻市場：依最終用戶分類

  • 健身中心和健身房
  • 家庭用戶
  • 醫院和診所
  • 職業運動員和教練
  • 研究機構

第10章全球生物阻抗電阻市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章 主要進展

  • 協議、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Akern Srl
  • Analog Devices
  • BIOSPACE Co., Ltd.
  • Bodystat Ltd.
  • Charder Electronic Co., Ltd.
  • ImpediMed Limited
  • InBody Co., Ltd.
  • LAICA SpA
  • Maltron International Ltd.
  • Medical Electronic Construction
  • Omron Healthcare, Inc.
  • RJL Systems, Inc.
  • seca GmbH & Co. KG
  • SELVAS Healthcare, Inc.
  • Spectra Medical Devices, Inc.
  • Tanita Corporation
  • Valhalla Scientific, Inc.
  • Xiaomi
  • Xitron Technologies
Product Code: SMRC25741

According to Stratistics MRC, the Global Bioimpedance Analyzers Market is accounted for $530.5 million in 2023 and is expected to reach $1087.7 million by 2030 growing at a CAGR of 10.8% during the forecast period. Bioimpedance analyzers are devices used to measure the electrical impedance of biological tissues. By applying a small electrical current to the body and measuring the resulting voltage, these analyzers estimate body composition parameters such as fat mass, lean body mass, and total body water. They are commonly used in healthcare, fitness, and research settings to assess hydration status and monitor changes in body composition over time.

According to the International Diabetes Federation (IDF) data published in 2021, globally, there were 537 million people years affected by diabetes aged between 20 to79 in 2021.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases and obesity

Bioimpedance analyzers are pivotal in assessing body composition, including fat mass, muscle mass, and hydration levels, which are critical indicators of health and disease risk. With the global rise in chronic conditions such as diabetes, cardiovascular diseases, and metabolic disorders linked to obesity, there is a growing demand for tools like bioimpedance analyzers to facilitate early detection, monitoring, and management, driving market growth.

Restraint:

High cost associated with advanced bioimpedance analyzers

The high cost associated with advanced bioimpedance analyzers represents a significant restraint in the bioimpedance analyzers market. These sophisticated devices, equipped with advanced features and capabilities, often come with a hefty price tag, limiting their accessibility to certain demographic segments and healthcare facilities. Additionally, the initial investment required for purchasing and maintaining these analyzers may deter potential buyers, especially in resource-constrained settings.

Opportunity:

Increasing adoption of bioimpedance analyzers in home healthcare settings

These devices offer users the convenience of monitoring their body composition and health parameters from the comfort of their homes, empowering individuals to take proactive measures towards better health management. With the rise of telemedicine and remote patient monitoring, bioimpedance analyzers can facilitate timely interventions and personalized care plans. Additionally, advancements in portable and user-friendly designs enhance accessibility and encourage broader adoption among consumers seeking convenient health monitoring solutions.

Threat:

Competition from alternative body composition analysis methods

Methods like dual-energy X-ray absorptiometry (DEXA) and air displacement plethysmography (ADP) offer higher precision and accuracy compared to bioimpedance analysis. While bioimpedance analyzers are convenient and non-invasive, their accuracy may be perceived as inferior in clinical and research settings. This competition challenges the market's growth by potentially diverting demand towards more established and trusted techniques, especially in applications where precise body composition measurements are critical, such as medical diagnosis and sports performance analysis.

Covid-19 Impact:

The COVID-19 pandemic has both positively and negatively impacted the bioimpedance analyzers market. While there has been increased awareness of health monitoring and fitness due to the pandemic, disruptions in manufacturing, supply chains, and healthcare services have hindered market growth. However, the market is expected to rebound as healthcare systems recover, and there is a renewed focus on preventive healthcare and remote patient monitoring post-pandemic.

The segmental body measurement segment is expected to be the largest during the forecast period

The segmental body measurement segment is anticipated to dominate the bioimpedance analyzer market throughout the forecast period. This is primarily attributed to the growing emphasis on personalized fitness and healthcare, driving the demand for precise body composition analysis. Additionally, advancements in technology have led to the development of bioimpedance analyzers capable of accurately measuring segmental body composition, allowing for targeted interventions in areas such as weight management, sports performance optimization, and disease prevention.

The multi-frequency segment is expected to have the highest CAGR during the forecast period

The multi-frequency segment is poised to exhibit significant growth in the bioimpedance analyzers market during the forecast period. This is attributed to the increasing adoption of multi-frequency bioimpedance analyzers, which offer enhanced accuracy and reliability in measuring body composition. These analyzers provide more comprehensive data by assessing various tissues and fluid compartments within the body, thus catering to the increasing demand for advanced and precise body composition analysis in healthcare, fitness, and research applications.

Region with largest share:

North America is poised to maintain its dominance in the bioimpedance analyzers market. This is primarily due to factors such as the presence of well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and increasing awareness regarding preventive healthcare measures. Additionally, ongoing research and development activities, coupled with favorable government initiatives to promote healthcare innovations, are expected to further drive market growth in the region, solidifying North America's leading position in the bioimpedance analyzers market.

Region with highest CAGR:

Asia Pacific is positioned for rapid growth in the bioimpedance analyzers market. Factors such as the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about preventive healthcare measures are driving market expansion in the region. Additionally, improving healthcare infrastructure, technological advancements, and a large population base contribute to the burgeoning demand for bioimpedance analyzers. These factors collectively propel Asia Pacific towards significant growth opportunities and a prominent position in the global bioimpedance analyzers market.

Key players in the market

Some of the key players in Bioimpedance Analyzers Market include Akern Srl, Analog Devices, BIOSPACE Co., Ltd., Bodystat Ltd., Charder Electronic Co., Ltd., ImpediMed Limited, InBody Co., Ltd., LAICA S.p.A., Maltron International Ltd., Medical Electronic Construction, Omron Healthcare, Inc., RJL Systems, Inc., seca GmbH & Co. KG, SELVAS Healthcare, Inc., Spectra Medical Devices, Inc., Tanita Corporation, Valhalla Scientific, Inc., Xiaomi and Xitron Technologies.

Key Developments:

In September 2022, Xiaomi launched an eight-electrode body composition scale that provides up to 35 body composition analysis reports. This body fat scale adopts a dual-frequency bioimpedance measurement technology to provide accurate measurements.

In April 2022, InBody, a worldwide leader in body composition technology, is pleased to announce the release of its BWA 2.0 body water analyzer. This new professional-grade device expands upon the outputs measured by the InBody S10 to provide users with more detailed insights that demonstrate how variations in body composition and body water can affect wellbeing.

In March 2022, Analog Devices launched a low-power, high-performance analog front end built for wearable bioimpedance monitoring, MAX30009. This device promised clinical-grade vital sign measurement for patient assessment.

Product Types Covered:

  • Single-frequency
  • Dual-frequency
  • Multi-frequency

Modalities Covered:

  • Wired
  • Wireless

Usage Types Covered:

  • Consumer-grade
  • Professional-grade

Application Covered:

  • Biofeedback and Training
  • Body Hydration Monitoring
  • Fitness and Bodybuilding
  • Medical Diagnosis
  • Nutritional Assessment
  • Segmental Body Measurement
  • Whole Body Composition Measurement

End Users Covered:

  • Fitness Centers and Gyms
  • Home Users
  • Hospitals and Clinics
  • Professional Athletes and Trainers
  • Research Institutions

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioimpedance Analyzers Market, By Product Type

  • 5.1 Introduction
  • 5.2 Single-frequency
  • 5.3 Dual-frequency
  • 5.4 Multi-frequency

6 Global Bioimpedance Analyzers Market, By Modality

  • 6.1 Introduction
  • 6.2 Wired
  • 6.3 Wireless

7 Global Bioimpedance Analyzers Market, By Usage Type

  • 7.1 Introduction
  • 7.2 Consumer-grade
  • 7.3 Professional-grade

8 Global Bioimpedance Analyzers Market, By Application

  • 8.1 Introduction
  • 8.2 Biofeedback and Training
  • 8.3 Body Hydration Monitoring
  • 8.4 Fitness and Bodybuilding
  • 8.5 Medical Diagnosis
  • 8.6 Nutritional Assessment
  • 8.7 Segmental Body Measurement
  • 8.8 Whole Body Composition Measurement

9 Global Bioimpedance Analyzers Market, By End User

  • 9.1 Introduction
  • 9.2 Fitness Centers and Gyms
  • 9.3 Home Users
  • 9.4 Hospitals and Clinics
  • 9.5 Professional Athletes and Trainers
  • 9.6 Research Institutions

10 Global Bioimpedance Analyzers Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Akern Srl
  • 12.2 Analog Devices
  • 12.3 BIOSPACE Co., Ltd.
  • 12.4 Bodystat Ltd.
  • 12.5 Charder Electronic Co., Ltd.
  • 12.6 ImpediMed Limited
  • 12.7 InBody Co., Ltd.
  • 12.8 LAICA S.p.A.
  • 12.9 Maltron International Ltd.
  • 12.10 Medical Electronic Construction
  • 12.11 Omron Healthcare, Inc.
  • 12.12 RJL Systems, Inc.
  • 12.13 seca GmbH & Co. KG
  • 12.14 SELVAS Healthcare, Inc.
  • 12.15 Spectra Medical Devices, Inc.
  • 12.16 Tanita Corporation
  • 12.17 Valhalla Scientific, Inc.
  • 12.18 Xiaomi
  • 12.19 Xitron Technologies

List of Tables

  • Table 1 Global Bioimpedance Analyzers Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bioimpedance Analyzers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bioimpedance Analyzers Market Outlook, By Single-frequency (2021-2030) ($MN)
  • Table 4 Global Bioimpedance Analyzers Market Outlook, By Dual-frequency (2021-2030) ($MN)
  • Table 5 Global Bioimpedance Analyzers Market Outlook, By Multi-frequency (2021-2030) ($MN)
  • Table 6 Global Bioimpedance Analyzers Market Outlook, By Modality (2021-2030) ($MN)
  • Table 7 Global Bioimpedance Analyzers Market Outlook, By Wired (2021-2030) ($MN)
  • Table 8 Global Bioimpedance Analyzers Market Outlook, By Wireless (2021-2030) ($MN)
  • Table 9 Global Bioimpedance Analyzers Market Outlook, By Usage Type (2021-2030) ($MN)
  • Table 10 Global Bioimpedance Analyzers Market Outlook, By Consumer-grade (2021-2030) ($MN)
  • Table 11 Global Bioimpedance Analyzers Market Outlook, By Professional-grade (2021-2030) ($MN)
  • Table 12 Global Bioimpedance Analyzers Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Bioimpedance Analyzers Market Outlook, By Biofeedback and Training (2021-2030) ($MN)
  • Table 14 Global Bioimpedance Analyzers Market Outlook, By Body Hydration Monitoring (2021-2030) ($MN)
  • Table 15 Global Bioimpedance Analyzers Market Outlook, By Fitness and Bodybuilding (2021-2030) ($MN)
  • Table 16 Global Bioimpedance Analyzers Market Outlook, By Medical Diagnosis (2021-2030) ($MN)
  • Table 17 Global Bioimpedance Analyzers Market Outlook, By Nutritional Assessment (2021-2030) ($MN)
  • Table 18 Global Bioimpedance Analyzers Market Outlook, By Segmental Body Measurement (2021-2030) ($MN)
  • Table 19 Global Bioimpedance Analyzers Market Outlook, By Whole Body Composition Measurement (2021-2030) ($MN)
  • Table 20 Global Bioimpedance Analyzers Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Bioimpedance Analyzers Market Outlook, By Fitness Centers and Gyms (2021-2030) ($MN)
  • Table 22 Global Bioimpedance Analyzers Market Outlook, By Home Users (2021-2030) ($MN)
  • Table 23 Global Bioimpedance Analyzers Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 24 Global Bioimpedance Analyzers Market Outlook, By Professional Athletes and Trainers (2021-2030) ($MN)
  • Table 25 Global Bioimpedance Analyzers Market Outlook, By Research Institutions (2021-2030) ($MN)
  • Table 26 Global Bioimpedance Analyzers Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.